Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2010

Open Access 01-12-2010 | Research

Prevalence of adrenal masses in Japanese patients with type 2 diabetes mellitus

Authors: Naoki Hiroi, Mariko Sue, Aya Yoshihara, Takamasa Ichijo, Mayumi Yoshida-Hiroi, Mariko Higa, Gen Yoshino

Published in: Diabetology & Metabolic Syndrome | Issue 1/2010

Login to get access

Abstract

Introduction

To date, there have been no reports on the prevalence of adrenal masses in type 2 diabetic patients. The present study aimed to evaluate the prevalence of adrenal incidentaloma in type 2 diabetic patients in Japan.

Subjects

We retrospectively evaluated the presence of adrenal masses using abdominal CT scans in 304 type 2 diabetic patients. In those with adrenal masses, we examined the hormone production capacity of the adrenal mass.

Results

Fourteen patients (4.6%) had an adrenal mass. Hormonal analysis identified one case as having subclinical Cushing's syndrome, two with primary aldosteronism. Eleven cases had non-functioning masses.

Discussion

The reported prevalence of adrenal incidentaloma in normal subjects is 0.6-4.0% in abdominal CT scan series. Our results show a relatively high prevalence of adrenal tumors in diabetic patients. On the other hand, the frequency of functional adenoma in diabetic patients is 21.4%, which is similar to that of normal subjects.

Conclusion

Although further studies are needed to evaluate the prevalence of adrenal tumors in diabetic patients, our data suggest that evaluation of the presence of adrenal masses may be needed in patients with type 2 diabetes mellitus.
Appendix
Available only for authorised users
Literature
1.
go back to reference Brunt LM, Moley JF: Adrenal incidentaloma. World J Surg. 2001, 25: 905-13. 10.1007/s00268-001-0029-0.CrossRefPubMed Brunt LM, Moley JF: Adrenal incidentaloma. World J Surg. 2001, 25: 905-13. 10.1007/s00268-001-0029-0.CrossRefPubMed
2.
go back to reference Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B: Incidentally discovered adrenal masses. Endocr Rev. 1995, 16: 460-484.PubMed Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B: Incidentally discovered adrenal masses. Endocr Rev. 1995, 16: 460-484.PubMed
3.
go back to reference Grumbach MM, Biller BM, Braunstein GD, Campbell KK, Carney JA, Godley PA, Harris EL, Lee JK, Oertel YC, Posner MC, Schlechte JA, Wieand HS: Management of the clinically inapparent adrenal mass ("incidentaloma"). Ann Intern Med. 2003, 138: 424-429.CrossRefPubMed Grumbach MM, Biller BM, Braunstein GD, Campbell KK, Carney JA, Godley PA, Harris EL, Lee JK, Oertel YC, Posner MC, Schlechte JA, Wieand HS: Management of the clinically inapparent adrenal mass ("incidentaloma"). Ann Intern Med. 2003, 138: 424-429.CrossRefPubMed
4.
go back to reference Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y, Bornstein SR: The Clinically Inapparent Adrenal Mass: Update in Diagnosis and Management. Endocr Rev. 2004, 25: 309-40. 10.1210/er.2002-0031.CrossRefPubMed Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y, Bornstein SR: The Clinically Inapparent Adrenal Mass: Update in Diagnosis and Management. Endocr Rev. 2004, 25: 309-40. 10.1210/er.2002-0031.CrossRefPubMed
5.
go back to reference Midorikawa S, Sanada H, Hashimoto S, Suzuki T, Watanabe T: The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection. Clin Endocrinol (Oxf). 2001, 54: 797-804. 10.1046/j.1365-2265.2001.01274.x.CrossRef Midorikawa S, Sanada H, Hashimoto S, Suzuki T, Watanabe T: The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection. Clin Endocrinol (Oxf). 2001, 54: 797-804. 10.1046/j.1365-2265.2001.01274.x.CrossRef
6.
go back to reference Reincke M, Fassnacht M, Väth S, Mora P, Allolio B: Adrenal incidentalomas: a manifestation of the metabolic syndrome?. Endocr Res. 1996, 22: 757-61.PubMed Reincke M, Fassnacht M, Väth S, Mora P, Allolio B: Adrenal incidentalomas: a manifestation of the metabolic syndrome?. Endocr Res. 1996, 22: 757-61.PubMed
7.
go back to reference Gross MD, Shapiro B: Clinically silent adrenal masses. J Clin Endocrinol Metab. 1993, 77: 885-888. 10.1210/jc.77.4.885.PubMed Gross MD, Shapiro B: Clinically silent adrenal masses. J Clin Endocrinol Metab. 1993, 77: 885-888. 10.1210/jc.77.4.885.PubMed
8.
go back to reference Hamrahian AH, Ioachimescu AG, Remer EM, Motta-Ramirez G, Bogabathina H, Levin HS, Reddy S, Gill IS, Siperstein A, Bravo EL: Clinical Utility of Noncontrast Computed Tomography Attenuation Value (Hounsfield Units) to Differentiate Adrenal Adenomas/Hyperplasias from Nonadenomas: Cleveland Clinic Experience. J Clin Endocrinol Metab. 2005, 90: 871-877. 10.1210/jc.2004-1627.CrossRefPubMed Hamrahian AH, Ioachimescu AG, Remer EM, Motta-Ramirez G, Bogabathina H, Levin HS, Reddy S, Gill IS, Siperstein A, Bravo EL: Clinical Utility of Noncontrast Computed Tomography Attenuation Value (Hounsfield Units) to Differentiate Adrenal Adenomas/Hyperplasias from Nonadenomas: Cleveland Clinic Experience. J Clin Endocrinol Metab. 2005, 90: 871-877. 10.1210/jc.2004-1627.CrossRefPubMed
9.
go back to reference Nawata H, Demura H, Suda T, Takayanagi R: Adrenal preclinical Cushing's syndrome. Annual report of the Ministry of Health and Welfare 'Disorder of Adrenal Hormones' Research Committee, Japan. 1996, 223-226. (In Japanese) Nawata H, Demura H, Suda T, Takayanagi R: Adrenal preclinical Cushing's syndrome. Annual report of the Ministry of Health and Welfare 'Disorder of Adrenal Hormones' Research Committee, Japan. 1996, 223-226. (In Japanese)
10.
go back to reference Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T: Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res. 2004, 27: 193-202. 10.1291/hypres.27.193.CrossRefPubMed Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T: Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res. 2004, 27: 193-202. 10.1291/hypres.27.193.CrossRefPubMed
11.
go back to reference Nishikawa T, Saito J, Omura M: Prevalence of primary aldosteronism: should we screen for primary aldosteronism before treating hypertensive patients with medication?. Endocr J. 2007, 54: 487-495. 10.1507/endocrj.KR-105.CrossRefPubMed Nishikawa T, Saito J, Omura M: Prevalence of primary aldosteronism: should we screen for primary aldosteronism before treating hypertensive patients with medication?. Endocr J. 2007, 54: 487-495. 10.1507/endocrj.KR-105.CrossRefPubMed
12.
go back to reference Arlt W: A detour guide to the Endocrine Society Clinical Practice Guideline on case detection, diagnosis and treatment of patients with primary aldosteronism. Eur J Endocrinol. 2010, 162: 435-438. 10.1530/EJE-09-0869.CrossRefPubMed Arlt W: A detour guide to the Endocrine Society Clinical Practice Guideline on case detection, diagnosis and treatment of patients with primary aldosteronism. Eur J Endocrinol. 2010, 162: 435-438. 10.1530/EJE-09-0869.CrossRefPubMed
13.
go back to reference Nohta H, Lee MK, Ohkura Y: Fluorescence products of the reaction for the determination of catecholamines with 1,2-diarylethylendiamines. Analytica Chimica Acta. 1992, 267: 137-139. 10.1016/0003-2670(92)85015-X.CrossRef Nohta H, Lee MK, Ohkura Y: Fluorescence products of the reaction for the determination of catecholamines with 1,2-diarylethylendiamines. Analytica Chimica Acta. 1992, 267: 137-139. 10.1016/0003-2670(92)85015-X.CrossRef
14.
go back to reference Meagher AP, Hugh TB, Casey JH, Chisholm DJ, Farrell JC, Yeates M: Primary adrenal tumours---a ten-year experience. Aust N Z J Surg. 1988, 58: 457-462. 10.1111/j.1445-2197.1988.tb06235.x.CrossRefPubMed Meagher AP, Hugh TB, Casey JH, Chisholm DJ, Farrell JC, Yeates M: Primary adrenal tumours---a ten-year experience. Aust N Z J Surg. 1988, 58: 457-462. 10.1111/j.1445-2197.1988.tb06235.x.CrossRefPubMed
15.
go back to reference Abecassis M, McLoughlin MJ, Langer B, Kudlow JE: Serendipitous adrenal masses: prevalence, significance, and management. Am J Surg. 1985, 149: 783-788. 10.1016/S0002-9610(85)80186-0.CrossRefPubMed Abecassis M, McLoughlin MJ, Langer B, Kudlow JE: Serendipitous adrenal masses: prevalence, significance, and management. Am J Surg. 1985, 149: 783-788. 10.1016/S0002-9610(85)80186-0.CrossRefPubMed
16.
go back to reference Hedeland H, Ostberg G, Hokfelt B: On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes. Acta Med Scand. 1968, 184: 211-214. 10.1111/j.0954-6820.1968.tb02445.x.CrossRefPubMed Hedeland H, Ostberg G, Hokfelt B: On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes. Acta Med Scand. 1968, 184: 211-214. 10.1111/j.0954-6820.1968.tb02445.x.CrossRefPubMed
17.
go back to reference Glazer HS, Weyman PJ, Sagel SS, Levitt RG, McClennan BL: Nonfunctioning adrenal masses: incidental discovery on computed tomography. AJR Am J Roentgenol. 1982, 139: 81-85.CrossRefPubMed Glazer HS, Weyman PJ, Sagel SS, Levitt RG, McClennan BL: Nonfunctioning adrenal masses: incidental discovery on computed tomography. AJR Am J Roentgenol. 1982, 139: 81-85.CrossRefPubMed
18.
go back to reference Caplan RH, Strutt PJ, Wickus GG: Subclinical hormone secretion by incidentally discovered adrenal masses. Arch Surg. 1994, 129: 291-296.CrossRefPubMed Caplan RH, Strutt PJ, Wickus GG: Subclinical hormone secretion by incidentally discovered adrenal masses. Arch Surg. 1994, 129: 291-296.CrossRefPubMed
19.
go back to reference Prinz RA, Brooks MH, Churchill R, Graner JL, Lawrence AM, Paloyan E, Sparagana M: Incidental asymptomatic adrenal masses detected by computed tomographic scanning. Is operation required?. JAMA. 1982, 248: 701-704. 10.1001/jama.248.6.701.CrossRefPubMed Prinz RA, Brooks MH, Churchill R, Graner JL, Lawrence AM, Paloyan E, Sparagana M: Incidental asymptomatic adrenal masses detected by computed tomographic scanning. Is operation required?. JAMA. 1982, 248: 701-704. 10.1001/jama.248.6.701.CrossRefPubMed
20.
go back to reference Bovio S, Cataldi A, Reimondo G, Sperone P, Novello S, Berruti A, Borasio P, Fava C, Dogliotti L, Scagliotti GV, Angeli A, Terzolo M: Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Invest. 2006, 29: 298-302.CrossRefPubMed Bovio S, Cataldi A, Reimondo G, Sperone P, Novello S, Berruti A, Borasio P, Fava C, Dogliotti L, Scagliotti GV, Angeli A, Terzolo M: Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. J Endocrinol Invest. 2006, 29: 298-302.CrossRefPubMed
21.
go back to reference Terzolo M, Osella G, Alì A, Borretta G, Magro GP, Termine A, Paccotti P, Angeli A: Different patterns of steroid secretion in patients with adrenal incidentaloma. J Clin Endocrinol Metab. 1996, 81: 740-744. 10.1210/jc.81.2.740.PubMed Terzolo M, Osella G, Alì A, Borretta G, Magro GP, Termine A, Paccotti P, Angeli A: Different patterns of steroid secretion in patients with adrenal incidentaloma. J Clin Endocrinol Metab. 1996, 81: 740-744. 10.1210/jc.81.2.740.PubMed
22.
go back to reference Fernandez-Real JM, Ricart EW, Simò R, Salinas I, Webb SM: Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours. Clin Endocrinol (Oxf). 1998, 49: 53-61. 10.1046/j.1365-2265.1998.00437.x.CrossRef Fernandez-Real JM, Ricart EW, Simò R, Salinas I, Webb SM: Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours. Clin Endocrinol (Oxf). 1998, 49: 53-61. 10.1046/j.1365-2265.1998.00437.x.CrossRef
23.
go back to reference Muscogiuri G, Sorice GP, Prioletta A, Mezza T, Cipolla C, Salomone E, Giaccari A, Pontecorvi A, Casa SD: The size of adrenal incidentalomas correlates with insulin resistance. Is there a cause-effect relationship?. Clin Endocrinol (Oxf). 2010, Muscogiuri G, Sorice GP, Prioletta A, Mezza T, Cipolla C, Salomone E, Giaccari A, Pontecorvi A, Casa SD: The size of adrenal incidentalomas correlates with insulin resistance. Is there a cause-effect relationship?. Clin Endocrinol (Oxf). 2010,
24.
go back to reference Barzon L, Sonino N, Fallo F, Palu G, Boscaro M: Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol. 2003, 149 (4): 273-85. 10.1530/eje.0.1490273.CrossRefPubMed Barzon L, Sonino N, Fallo F, Palu G, Boscaro M: Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol. 2003, 149 (4): 273-85. 10.1530/eje.0.1490273.CrossRefPubMed
25.
go back to reference Ueshiba H, Ichijo T, Yamamoto N: A survey of adrenal incidentaloma in Japan. Annual report of the Health and Labour Science Research Grant 'Disorder of Adrenal Hormones' Research Committee, Japan. 2003, 117-119. (In Japanese) Ueshiba H, Ichijo T, Yamamoto N: A survey of adrenal incidentaloma in Japan. Annual report of the Health and Labour Science Research Grant 'Disorder of Adrenal Hormones' Research Committee, Japan. 2003, 117-119. (In Japanese)
26.
go back to reference Kim HY, Kim SG, Lee KW, Seo JA, Kim NH, Choi KM, Baik SH, Choi DS: Clinical study of adrenal incidentaloma in Korea. Korean J Intern Med. 2005, 20: 303-309.PubMedCentralCrossRefPubMed Kim HY, Kim SG, Lee KW, Seo JA, Kim NH, Choi KM, Baik SH, Choi DS: Clinical study of adrenal incidentaloma in Korea. Korean J Intern Med. 2005, 20: 303-309.PubMedCentralCrossRefPubMed
27.
go back to reference Leibowitz G, Tsur A, Chayen SD, Salameh M, Raz I, Cerasi E, Gross DJ: Pre-clinical Cushing's syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients. Clin Endocrinol (Oxf). 1996, 44: 717-722. 10.1046/j.1365-2265.1996.737558.x.CrossRef Leibowitz G, Tsur A, Chayen SD, Salameh M, Raz I, Cerasi E, Gross DJ: Pre-clinical Cushing's syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients. Clin Endocrinol (Oxf). 1996, 44: 717-722. 10.1046/j.1365-2265.1996.737558.x.CrossRef
28.
go back to reference Catargi B, Rigalleau V, Poussin A, Ronci-Chaix N, Bex V, Vergnot V, Gin H, Roger P, Tabarin A: Occult Cushing's syndrome in type-2 diabetes. J Clin Endocrinol Metab. 2003, 88: 5808-5813. 10.1210/jc.2003-030254.CrossRefPubMed Catargi B, Rigalleau V, Poussin A, Ronci-Chaix N, Bex V, Vergnot V, Gin H, Roger P, Tabarin A: Occult Cushing's syndrome in type-2 diabetes. J Clin Endocrinol Metab. 2003, 88: 5808-5813. 10.1210/jc.2003-030254.CrossRefPubMed
29.
go back to reference Chiodini I, Torlontano M, Scillitani A, Arosio M, Bacci S, Di Lembo S, Epaminonda P, Augello G, Enrini R, Ambrosi B, Adda G, Trischitta V: Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients. Eur J Endocrinol. 2005, 153 (6): 837-44. 10.1530/eje.1.02045.CrossRefPubMed Chiodini I, Torlontano M, Scillitani A, Arosio M, Bacci S, Di Lembo S, Epaminonda P, Augello G, Enrini R, Ambrosi B, Adda G, Trischitta V: Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients. Eur J Endocrinol. 2005, 153 (6): 837-44. 10.1530/eje.1.02045.CrossRefPubMed
30.
go back to reference Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM: The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008, 93: 1526-1540. 10.1210/jc.2008-0125.PubMedCentralCrossRefPubMed Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM: The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008, 93: 1526-1540. 10.1210/jc.2008-0125.PubMedCentralCrossRefPubMed
31.
go back to reference Rowe JW, Tobin JD, Rosa RM, Andres R: Effect of experimental potassium deficiency on glucose and insulin metabolism. Metabolism. 1980, 29: 498-502. 10.1016/0026-0495(80)90074-8.CrossRefPubMed Rowe JW, Tobin JD, Rosa RM, Andres R: Effect of experimental potassium deficiency on glucose and insulin metabolism. Metabolism. 1980, 29: 498-502. 10.1016/0026-0495(80)90074-8.CrossRefPubMed
32.
go back to reference Catena C, Lapenna R, Baroselli S, Nadalini E, Colussi GL, Novello M, Favret G, Melis A, Cavarape A, Sechi LA: Insulin sensitivity in patients with primary aldosteronism: a follow-up study. J Clin Endocrinol Metab. 2006, 91: 3457-3463. 10.1210/jc.2006-0736.CrossRefPubMed Catena C, Lapenna R, Baroselli S, Nadalini E, Colussi GL, Novello M, Favret G, Melis A, Cavarape A, Sechi LA: Insulin sensitivity in patients with primary aldosteronism: a follow-up study. J Clin Endocrinol Metab. 2006, 91: 3457-3463. 10.1210/jc.2006-0736.CrossRefPubMed
33.
go back to reference Colussi G, Catena C, Lapenna R, Nadalini E, Chiuch A, Sechi LA: Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients. Diabetes Care. 2007, 30: 2349-2354. 10.2337/dc07-0525.CrossRefPubMed Colussi G, Catena C, Lapenna R, Nadalini E, Chiuch A, Sechi LA: Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients. Diabetes Care. 2007, 30: 2349-2354. 10.2337/dc07-0525.CrossRefPubMed
34.
go back to reference Ward AM, Fall CH, Stein CE, Kumaran K, Veena SR, Wood PJ, Syddall HE, Phillips DI: Cortisol and the metabolic syndrome in South Asians. Clin Endocrinol (Oxf). 2003, 58: 500-505. 10.1046/j.1365-2265.2003.01750.x.CrossRef Ward AM, Fall CH, Stein CE, Kumaran K, Veena SR, Wood PJ, Syddall HE, Phillips DI: Cortisol and the metabolic syndrome in South Asians. Clin Endocrinol (Oxf). 2003, 58: 500-505. 10.1046/j.1365-2265.2003.01750.x.CrossRef
35.
go back to reference Delaunay F, Khan A, Cintra A, Davani B, Ling ZC, Andersson A, Ostenson CG, Gustafsson J, Efendic S, Okret S: Pancreatic β-cells are important targets for the diabetogenic effects of glucocorticoids. J Clin Invest. 1997, 100: 2094-2098. 10.1172/JCI119743.PubMedCentralCrossRefPubMed Delaunay F, Khan A, Cintra A, Davani B, Ling ZC, Andersson A, Ostenson CG, Gustafsson J, Efendic S, Okret S: Pancreatic β-cells are important targets for the diabetogenic effects of glucocorticoids. J Clin Invest. 1997, 100: 2094-2098. 10.1172/JCI119743.PubMedCentralCrossRefPubMed
36.
go back to reference Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Alì A, Giovagnetti M, Opocher G, Angeli A: A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab. 2000, 85: 637-644. 10.1210/jc.85.2.637.PubMed Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Alì A, Giovagnetti M, Opocher G, Angeli A: A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab. 2000, 85: 637-644. 10.1210/jc.85.2.637.PubMed
37.
go back to reference Herrera MF, Grant CS, van Heerden JA, Sheedy PF, Ilstrup DM: Incidentally discovered adrenal tumors: an institutional perspective. Surgery. 1991, 110: 1014-1021.PubMed Herrera MF, Grant CS, van Heerden JA, Sheedy PF, Ilstrup DM: Incidentally discovered adrenal tumors: an institutional perspective. Surgery. 1991, 110: 1014-1021.PubMed
38.
go back to reference Barzon L, Fallo F, Sonino N, Boscaro M: Development of overt Cushing's syndrome in patients with adrenal incidentaloma. Eur J Endocrinol. 2002, 146: 61-66. 10.1530/eje.0.1460061.CrossRefPubMed Barzon L, Fallo F, Sonino N, Boscaro M: Development of overt Cushing's syndrome in patients with adrenal incidentaloma. Eur J Endocrinol. 2002, 146: 61-66. 10.1530/eje.0.1460061.CrossRefPubMed
39.
go back to reference Reincke M, Nieke J, Krestin GP, Saeger W, Allolio B, Winkelmann W: Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome. J Clin Endocrinol Metab. 1992, 75: 826-832. 10.1210/jc.75.3.826.PubMed Reincke M, Nieke J, Krestin GP, Saeger W, Allolio B, Winkelmann W: Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome. J Clin Endocrinol Metab. 1992, 75: 826-832. 10.1210/jc.75.3.826.PubMed
Metadata
Title
Prevalence of adrenal masses in Japanese patients with type 2 diabetes mellitus
Authors
Naoki Hiroi
Mariko Sue
Aya Yoshihara
Takamasa Ichijo
Mayumi Yoshida-Hiroi
Mariko Higa
Gen Yoshino
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2010
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/1758-5996-2-71

Other articles of this Issue 1/2010

Diabetology & Metabolic Syndrome 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.